@article{ref1,
title="Antidepressant use in children and adolescents",
journal="Archives de Pediatrie",
year="2009",
author="Bailly, D.",
volume="16",
number="10",
pages="1415-1418",
abstract="Relative to placebo, selective serotonin reuptake inhibitors (SSRI) are efficacious for paediatric affective disorders, although their clinical effects appear relatively modest in major depressive disorder, intermediate in obsessive-compulsive disorder, and stronger in anxiety disorders. If SSRIs modestly increase the risk of occurrence of suicidal ideation and behavior, several studies show that their use is associated with a significant decrease in the suicide rates in children and adolescents, probably because of their efficacy, compliance, and low toxicity in overdose.<p /><p>Language: fr</p>",
language="fr",
issn="0929-693X",
doi="10.1016/j.arcped.2009.03.017",
url="http://dx.doi.org/10.1016/j.arcped.2009.03.017"
}